Validity of the Musculoskeletal Tumor Society Score for lower extremity in patients with bone sarcoma or giant cell tumour of bone undergoing bone resection and reconstruction surgery in hip and knee. [PDF]
BMC CancerSherling N +4 more
europepmc +1 more source
Deep Circumflex Iliac Artery Osteoseptocutaneous Flap as a Reconstruction Method for Distal Radius Recurrent Giant Cell Tumour in the Case of a Bilateral Peroneal Magna Artery: An Eight-Year Follow-Up. [PDF]
CureusMohamed Haflah NH +5 more
europepmc +1 more source
Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal. [PDF]
J Bone OncolMachak GN +3 more
europepmc +1 more source
Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features
Skeletal Radiology, 2021 Giant cell tu mour accounts for up to 5% of all bone tumours and malignant giant cell tumour arises in \u3c 10% of cases, representing sarcomatous transformation.
Ismail Tahir
exaly +2 more sources
Related searches:
Management of tenosynovial giant cell tumour of the foot and ankle
Bone and Joint Journal, 2021Hans J. Gelderblom +2 more
exaly
The role of Denosumab in joint preservation for patients with giant cell tumour of bone
Bone and Joint Journal, 2021Julia Visgauss +2 more
exaly
Osteoclast-like giant cell tumour of the urinary bladder
Histopathology, 1990G Amir, E Rosenmann
exaly
The current standing on the use of denosumab in giant cell tumour of the bone
Journal of Orthopaedic Surgery, 2020Vivek Ajit Singh, Ajay Puri
exaly